drugset / Trial / NCT01065545
The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia
Phase 1
Withdrawn
Northwestern University
Genzyme, a Sanofi Company · collabLoyola University · collabRush University Medical Center · collabUniversity of Illinois at Chicago · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the side effects of the study drug, clofarabine, when given by mouth to patients with acute myeloid leukemia (AML), in remission.
Timeline
- Start
- 2011-06
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Business): “Due to funding issues.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clofarabine | Other / unclassified | — | Oral |